Fatty Acids, Obesity, and Insulin Resistance: Time for a Reevaluation
Open accessThe DOI matches its Crossref record; 90 of the 91 references it cites were found in a registry or an index.
Abstract
There is a widespread acceptance in the literature that plasma nonesterified fatty acids (NEFA), also called free fatty acids (FFA), can mediate many adverse metabolic effects, most notably insulin resistance. Elevated NEFA concentrations in obesity are thought to arise from an increased adipose tissue mass. It is also argued that the process of fatty acid mobilization from adipose tissue, normally suppressed by insulin, itself becomes insulin resistant—thus, lipolysis is further increased, potentially leading to a vicious cycle. Although we have also accepted this model for many years (1,2), recently there has been a steady accumulation of data, both in the literature and from our own research, that has forced us to realize that this simple story is not always true. Here we review the background to the idea of “fatty acids as metabolic villains,” together with data from the literature and from our own studies, which tend to show another side to the fatty acids/insulin resistance story. We will first examine the relationship between systemic concentrations of NEFA and obesity/insulin resistance and then study adipose tissue in the obese state with regard to its adaptation for NEFA release. NEFA circulate in the plasma bound to plasma albumin. Their function was largely elucidated in the 1950s through the work of Vincent Dole (3) at the Rockefeller Institute in New York and Robert Gordon (4,5) at the National Institutes of Health. Gordon demonstrated the origin of plasma NEFA from adipose tissue and their use by tissues such as the liver and myocardium, but not the brain. We now recognize that NEFA are the vehicle by which triacylglycerol (TG) stored in adipose tissue is transported to its sites of utilization. NEFA turnover is rapid, with a plasma half-life around 2–4 min (6). The only significant site of NEFA liberation …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The amount of liberated FFA from chylomicrons and VLDL depends on the activity of LPL, which is stimulated by insulin [17,18].”
From Dyslipidemia in obesity: Mechanisms and potential targets (2013) · cites this paper as [17]
Experimental — accuracy not yet measuredIn the citing paper
“These observations suggest that carbohydrate restriction reduces insulin secretion, which may facilitate fat mobilization (33), particularly from the intra-abdominal area, a depot associated with metabolic dysfunction that is enlarged in individuals with T2D (34,35).”
From A Lower-Carbohydrate, Higher-Fat Diet Reduces Abdominal and Intermuscular Fat and Increases Insulin Sensitivity in Adults at Risk of Type 2 Diabetes (2015) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,550
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,705 · cited 1×
“With this approach, it is easy to show that elevated NEFA concentrations are associated acutely with insulin resistance, both with peripheral glucose uptake (33,34) and hepatic gluconeogenesis (35,36) and with impaired glucose tolerance (37).”
BackgroundA RELATION BETWEEN NON-ESTERIFIED FATTY ACIDS IN PLASMA AND THE METABOLISM OF GLUCOSE
Dole, V. P. (1956) · Journal of Clinical Investigation · doi:10.1172/jci103259 · Cited by 3,454 · cited 1×
“Their function was largely elucidated in the 1950s through the work of Vincent Dole (3) at the Rockefeller Institute in New York and Robert Gordon (4,5) at the National Institutes of Health.”
BackgroundRomijn, J. A., Coyle, E. F., Sidossis, L. S., Gastaldelli, A., Horowitz, J. F., Endert, E., & Wolfe, R. R. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.265.3.e380 · Cited by 1,747 · cited 1×
“somewhat (2), but often plasma NEFA concentrations remain relatively stable as removal by muscle increases to match adipose tissue lipolysis (27,28).”
BackgroundLipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications
Unger, R. H. (1995) · Diabetes · doi:10.2337/diab.44.8.863 · Cited by 1,100 · cited 1×
“The detrimental effects on insulin sensitivity and other cellular processes are known as lipotoxicity (57).”
BackgroundSplanchnic lipolysis in human obesity
Nielsen, S., Guo, Z., Johnson, C. M., Hensrud, D. D., & Jensen, M. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21047 · Cited by 933 · cited 1×
“The abdominal subcutaneous fat depot is the dominant source of NEFA; considerably less comes from leg adipose tissue and—against popular belief—only a small proportion of the systemic NEFA concentrations arises from intraabdominal adipose tissue (7).”
BackgroundLipolysis and lipid mobilization in human adipose tissue
Lafontan, M., & Langin, D. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.05.001 · Cited by 826 · cited 1×
“It has been reviewed recently (8), and we will not cover those aspects here.”
BackgroundGroop, L. C., Bonadonna, R. C., DelPrato, S., Ratheiser, K., Zyck, K., Ferrannini, E., & DeFronzo, R. A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114142 · Cited by 812 · cited 2×
“The rationale for this supposition comes from the fact that adipose tissue could be seen as insulin resistant in obesity and therefore as not responding adequately to the antilipolytic action of insulin (29).”
Background
Cited by
Items 501–600 of 894
Moriyama, R., YAMAZAKI, T., Katō, T., & Kato, Y. (2016) · Journal of Reproduction and Development · doi:10.1262/jrd.2015-138 · Cited by 13
“The concentration of nonesterified fatty acids in the rodent peripheral blood is in the hundreds of micromolar range [25, 26]; therefore, the concentration of LCFAs used in this study is similar to the physiological level or even slightly lower than that recorded in rodent peripheral blood.”
BackgroundServiá, L., Jové, M., Sol, J., Pamplona, R., Badía, M., Montserrat, N., Portero‐Otín, M., & Trujillano, J. (2019) · Scandinavian Journal of Trauma Resuscitation and Emergency Medicine · doi:10.1186/s13049-019-0631-5 · Cited by 14
Adipose tissue metabolism and inflammation in obesity
van Meijel, R. L. J., Blaak, E. E., & Goossens, G. H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813553-2.00001-4 · Cited by 16
A meal enriched in saturated fat acutely impairs cognitive performance in obese men
Ruegsegger, G. N., Rappaport, C. I., Hill, J. J., Jochum, K. A., Challeen, E. S., & Roth, M. C. (2021) · Physiology & Behavior · doi:10.1016/j.physbeh.2021.113664 · Cited by 13
Considerations for choosing an optimal animal model of cardiovascular disease
Parikh, M., & Pierce, G. N. (2023) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2023-0206 · Cited by 13
Chapelain, T., Wilms, J. N., Martín‐Tereso, J., Leal, L. N., & Daniel, J. (2024) · Journal of Dairy Science · doi:10.3168/jds.2024-25556 · Cited by 12
Blaak, E. E. (2017) · Proceedings of The Nutrition Society · doi:10.1017/s0029665116003013 · Cited by 14
FSP27 and Links to Obesity and Diabetes Mellitus
Karki, S. (2019) · Current Obesity Reports · doi:10.1007/s13679-019-00343-3 · Cited by 15
Ilić, I., Oršolić, N., Rođak, E., Odeh, D., Lovrić, M., Mujkić, R., Aždajić, M. D., Grgić, A., Levak, M. T., Vargek, M., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238600 · Cited by 13
“Impaired intracellular signalling prevents glucose uptake into the cell [60].”
BackgroundPeng, K., Barlow, C. K., Kammoun, H. L., Mellett, N. A., Weir, J. M., Murphy, A. J., Febbraio, M. A., & Meikle, P. J. (2021) · Metabolites · doi:10.3390/metabo11030188 · Cited by 14
“Diabetes and obesity may further increase the FFA level the liver is exposed to [25,27].”
BackgroundRodríguez-López, L. A., Torre-Villalvazo, I., Alemán, G., Flores‐López, A., Guevara‐Cruz, M., Sánchez‐Tapia, M., Torre-Anaya, E. A., Martínez-López, V., Vásquez‐Reyes, S., Torres‐Villalobos, G., et al. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00921-3 · Cited by 14
Translational Aspects of the Mammalian Target of Rapamycin Complexes in Diabetic Nephropathy
Daher, A. A., Alkhansa, S., Azar, W. S., Rafeh, R. W., Ghadieh, H. E., & Eid, A. A. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0217 · Cited by 13
“In addition to hyperglycemia, levels of serum-free fatty acids (FFAs) are also elevated due to impaired insulin action and increased lipolysis (73).”
Serum Nonesterified Fatty Acids and Incident Stroke: The CHS
Huang, N. K., Biggs, M. L., Matthan, N. R., Djoussé, L., Longstreth, W. T., Mukamal, K. J., Siscovick, D. S., & Lichtenstein, A. H. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.022725 · Cited by 13
“11,12 Data from cross-sectional and prospective studies show a significant positive relation between plasma total NEFA concentrations and the risk factors for stroke development, including hypertension, 12,13 obesity, 14 diabetes, insulin resistance, 14,15 and recurrent embolic stroke.”
Maternal Diet, Oocyte Nutrition and Metabolism, and Offspring Health
Velazquez, M. A., & Fleming, T. P. (2012) · Springer eBooks · doi:10.1007/978-0-85729-826-3_22 · Cited by 13
“The effects of NEFA on oocyte physiology are not only relevant for undernutrition but also for obesity [ 259 ] .”
BackgroundMaeda, H., Hosomi, R., Koizumi, M., Toda, Y., Mitsui, M., & Fukunaga, K. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.01.038 · Cited by 12
Dias, J. P., Schrack, J. A., Shardell, M. D., Egan, J. M., & Studenski, S. A. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.04.015 · Cited by 12
“Additionally, excess levels of FFA are known to impair insulin receptor activity via the accumulation of FFA derived metabolic products that promote the activation of several intracellular molecular mechanisms such as activation of serine/threonine kinases, JNK (c-jun aminoterminal kinases), IKKb (inhibitor of nuclear…”
Lipophagy: A New Perspective of Natural Products in Type 2 Diabetes Mellitus Treatment
Huang, M., Yang, X., Wang, Z., Long, J., Wang, A., Zhang, Y., & Yan, D. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s310166 · Cited by 12
“which is important for these diseases caused by abnormal lipid metabolism.(87) However, in this review, we are more concerned about the process that lipophagy breaks down the LDs with”
BackgroundMagkos, F., Smith, G. I., Reeds, D. N., Okunade, A. L., Patterson, B. W., & Mittendorfer, B. (2013) · Obesity · doi:10.1002/oby.20562 · Cited by 14
“Increased plasma FFA availability is therefore most likely not involved in the pathogenesis of the acute overfeeding-induced insulin resistant glucose metabolism, which is consistent with the notion that insulin resistance in obese persons is not directly related to or caused by increased plasma FFA availability (25).”
Benedetti, S., Al‐Tannak, N. F., Alzharani, M. A., Moir, H. J., Stensel, D. J., Thackray, A. E., Naughton, D. P., Dorak, M. T., Spendiff, O., Hill, N. J., et al. (2019) · Metabolites · doi:10.3390/metabo9040071 · Cited by 13
Chen, Y.-T., Wang, C., Cheng, C.-P., Liu, F., Lee, C., Lee, H., & Peng, Y. (2021) · Cells · doi:10.3390/cells10092500 · Cited by 11
Light modulates glucose and lipid homeostasis via the sympathetic nervous system
Chen, X., Lin, E., Haghighatian, M. M., Shepard, L. W., Hattar, S. S., Kuruvilla, R., & Zhao, H. (2024) · Science Advances · doi:10.1126/sciadv.adp3284 · Cited by 13
“Under fasting conditions, plasma NEFA levels rise rapidly, and this process is tightly regulated, with insulin and sympathetic nerve– derived norepinephrine (NE) signaling being two major contributors ( 38 , 39 ).”
Duan, J., Chen, W., Zhao, Y., He, L., Li, E., Bai, Z., Wang, Y., & Zhang, C. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13898 · Cited by 13
Jackson, K. G., Newens, K. J., Fry, M. J., Thompson, A. K., & Williams, C. M. (2022) · European Journal of Nutrition · doi:10.1007/s00394-022-02821-2 · Cited by 11
“The total NEFA concentrations chosen for study were 400 μM and 800 μM to reflect the circulating postprandial NEFA concentrations reported in healthy and insulin-resistant individuals, respectively [17, 18].”
BackgroundFasting and Postload Nonesterified Fatty Acids and Glucose Dysregulation in Older Adults
Shitole, S. G., Biggs, M. L., Ix, J. H., Fretts, A. M., Tracy, R. P., Siscovick, D. S., Djoussé, L., Mukamal, K. J., & Kizer, J. R. (2022) · American Journal of Epidemiology · doi:10.1093/aje/kwac044 · Cited by 11
Moreira, V. C., Silva, C. M. S., Welker, A. F., & da Silva, I. C. R. (2022) · Journal of Aging Research · doi:10.1155/2022/8350527 · Cited by 13
Lövfors, W., Ekström, J., Jönsson, C., Strålfors, P., Cedersund, G., & Nyman, E. (2021) · PLoS ONE · doi:10.1371/journal.pone.0261681 · Cited by 13
“Type 2 diabetes and obesity have traditionally been associated with elevated levels of circulating fatty acids, an issue both challenged and affirmed [10, 18].”
BackgroundShort Term HIIT increase VO2max, but can’t decrease Free Fatty Acids in Women Sedentary Lifestyle
Syamsudin, F., Herawati, L., Qurnianingsih, E., Kinanti, R. G., Vigriawan, G. E., Cahyaningrum, E. A., As’ad, M. R. F., & Callixte, C. (2023) · Retos · doi:10.47197/retos.v50.99573 · Cited by 14
Phenotypic molecular features of long-lived animal species
Jové, M., Mota‐Martorell, N., Fernàndez‐Bernal, A., Portero‐Otín, M., Barja, G., & Pamplona, R. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.09.023 · Cited by 12
Extracellular Vimentin Alters Energy Metabolism And Induces Adipocyte Hypertrophy
Park, J.-H., Kwon, S., & Park, Y. M. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2022.0332 · Cited by 11
“However, elevated NEFA in serum promotes metabolic derangement such as insulin resistance [41].”
Johns, I., Goff, L. M., Bluck, L. J. C., Griffin, B. A., Jebb, S. A., Lovegrove, J. A., Sanders, T. A. B., Frost, G. S., & Dornhorst, A. (2014) · Diabetic Medicine · doi:10.1111/dme.12550 · Cited by 14
Relevance of liver fat to the impact of dietary extrinsic sugars on lipid metabolism
Griffin, B. A. (2015) · Proceedings of The Nutrition Society · doi:10.1017/s0029665115002050 · Cited by 11
Dahabiyeh, L. A., Bustanji, Y. K., & Taha, M. O. (2018) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13463 · Cited by 11
Sathyanarayana, A. R., Lu, C., Liaw, C., Chang, C., Han, H.-Y., Green, B. D., Huang, W., Huang, C., He, W.-D., Lee, L., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23074052 · Cited by 11
Madeira, M. S. M. D. S., Rolo, E. A., Lopes, P. A., Ramos, D. A., Alfaia, C. M., Pires, V. M. R., Martins, S. V., Pinto, R. M. A., & Prates, J. A. M. (2017) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.8504 · Cited by 13
Rusli, F., Boekschoten, M. V., Borelli, V., Sun, C., Lute, C., Menke, A. L., van den Heuvel, J., Salvioli, S., Franceschi, C., Müller, M. M., et al. (2017) · Aging Cell · doi:10.1111/acel.12696 · Cited by 11
Adipocyte Phenotype Flexibility and Lipid Dysregulation
Preston, K. J., Scalia, R. G., & Autieri, M. V. (2022) · Cells · doi:10.3390/cells11050882 · Cited by 13
“Comparisons of metabolic variables, such as insulin sensitivity and the lipolytic rate between lean and obese adipose tissue, are obfuscated by differences in total adipose mass [76].”
BackgroundTricò, D., Rebelos, E., Astiarraga, B., Baldi, S., Scozzaro, T., Sacchetta, L., Chiriacò, M., Mari, A., Ferrannini, E., Muscelli, E., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae276 · Cited by 10
Dadson, P., Honka, M., Suomi, T., Haridas, P. A. N., Rokka, A., Palani, S., Goltseva, E., Wang, N., Roivainen, A., Salminen, P. T. P., et al. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00220.2024 · Cited by 11
Saghafi‐Asl, M., Amiri, P., Naghizadeh, M., Ghavami, S. M., & Karamzad, N. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-015910 · Cited by 12
Ma, S., Zhu, Z., & Cao, Z. (2020) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.13886 · Cited by 11
Koh, H. E., & Mittendorfer, B. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103311 · Cited by 12
“These results challenge some conventional wisdom, but are in line with the findings from other studies [8,9], and underscore the need for more mechanistic studies to understand the pathogenesis of metabolic dysfunction in people with obesity.”
ResultSasaki, N., Maeda, R., Ozono, R., Nakano, Y., & Higashi, Y. (2021) · Clinical Obesity · doi:10.1111/cob.12496 · Cited by 11
“However, inconsistent results have been reported regarding the association between obesity and serum FFA levels in clinical studies.(5,15,16) How obesity affects changes in serum FFA levels associated with the development of Type 2 diabetes from normal glucose status remains unclear.”
BackgroundNicolaisen, T. S., Sjøberg, K. A., Carl, C. S., Richter, E. A., Kiens, B., Fritzen, A. M., & Lundsgaard, A. (2024) · The FASEB Journal · doi:10.1096/fj.202302377r · Cited by 14
Insulin resistance in pregnancy complicated by type 1 diabetes mellitus. Do we know enough?
Gutaj, P., Sawicka‐Gutaj, N., Brązert, M., & Wender-Ożegowska, E. (2015) · Ginekologia Polska · doi:10.17772/gp/2065 · Cited by 12
Zhao, H., Jiang, X., Duan, L., Yang, L., Wang, W., & Ren, Z. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej19-0215 · Cited by 10
“Liraglutide (Lira), an important incretin glucagon-like peptide-1 (GLP-1) receptor agonist, exerted effective therapeutic effects not only in diabetes, but also in vari‐ ous diabetic complications [8].”
BackgroundSuppression of hyperinsulinemia restores growth hormone secretion and metabolism in obese mice
Huang, Z., Lu, X., Huang, L., Chen, Y., Zhang, C., Veldhuis, J. D., & Chen, C. (2021) · Journal of Endocrinology · doi:10.1530/joe-20-0616 · Cited by 10
Age-Related Cognitive Decline May Be Moderated by Frequency of Specific Food Products Consumption
Bramorska, A., Zarzycka, W., Podolecka, W., Kuć, K., & Brzezicka, A. (2021) · Nutrients · doi:10.3390/nu13082504 · Cited by 11
“Consuming simple carbohydrates and fat at the same time leads the organism to higher lipoprotein levels and higher insulin levels than when consuming those organic compounds separately [61,62].”
BackgroundThe Multifaceted Actions of Curcumin in Obesity
Bianconi, V., Pirro, M., Moallem, S. M. H., Majeed, M. A., Bronzo, P., D’Abbondanza, M., Jamialahmadi, T., & Sahebkar, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-73234-9_6 · Cited by 10
Gray, B. R., Steyn, F. J., Davies, P. S. W., & Vitetta, L. (2014) · Nutrition Research · doi:10.1016/j.nutres.2014.04.001 · Cited by 10
“in many cases leading to the normalization of free fatty acid levels in obese subjects [60].”
Olmstead, K. I., Frano, M. R. L., Fahrmann, J. F., Grapov, D., Viscarra, J. A., Newman, J. W. I., Fiehn, O., Crocker, D. E., Filipp, F. V., & Ortiz, R. M. (2017) · Metabolomics · doi:10.1007/s11306-017-1186-y · Cited by 10
“Glucose-stimulated insulin secretion, similar to what is achieved during an oral glucose tolerance test (oGTT), typically reduces plasma non-esterified free fatty acids (NEFA) (Karpe et al. 2011), and this response is consistent during early fasting in NES pups (Viscarra et al.”
BackgroundInfluentialEl papel de los ácidos grasos libres en la resistencia a la insulina
Vázquez-Jiménez, J. G., Roura-Guiberna, A., Jiménez-Mena, L. R., & Olivares-Reyes, J. A. (2017) · Gaceta Médica de México · doi:10.24875/gmm.17002714 · Cited by 26
Samkani, A., Skytte, M. J., Anholm, C., Astrup, A. V., Deacon, C. F., Holst, J. J., Madsbad, S., Boston, R., Krarup, T., & Haugaard, S. B. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0953-8 · Cited by 11
“Serum NEFA was analyzed using a commercially available reagent (Wako, NEFA-HR [2], Wako Che-micals GmbH, Neuss, Germany) with the ACS-ACOD Method [18, 19], providing CV 1.5% at all NEFA concentrations.”
MethodInfluentialNguyen, E. T., Berman, S., Streicher, J., Estrada, C. M., Caldwell, J. L., Ghisays, V., Ulrich‐Lai, Y. M., & Solomon, M. B. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00018.2019 · Cited by 12
Protective Actions of Polyphenols in the Development of Nonalcoholic Fatty Liver Disease
Lee, Y., & Lee, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814466-4.00008-2 · Cited by 10
Lestari, L. A., Ratnasari, D., Azizah, E. F., Farida, I. N., Nuriannisa, F., Yuliani, K., Kusuma, R. J., Huriyati, E., & Kertia, N. (2019) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/rjdnmd-2019-0041 · Cited by 13
“Insulin resistance also induce the lipolysis and release of plasma nonesterified fatty acid (NEFA) from adipose tissue [38], and approximately 60% of hepatic triglycerides are derived from plasma NEFA [39].”
BackgroundCappellari, G. G., Aleksova, A., Ferro, M. D., Cannata, A. N., Semolic, A., Zanetti, M., Springer, J., Anker, S. D., Giacca, M., Sinagra, G., et al. (2020) · Nutrients · doi:10.3390/nu12113393 · Cited by 9
“Elevated fat substrates could also per se directly enhance mitochondrial ATP production [29], and excess fatty acids may also indeed characterize obesity independently of dietary intake [37,53].”
BackgroundYahaya, T., Oladele, E. O., Mshelia, M. B., Sifau, M. O., Fashola, O. D., Bunza, M. D. A., & Nathaniel, J. (2021) · Bulletin of the National Research Centre/Bulletin of the National Research Center · doi:10.1186/s42269-021-00603-0 · Cited by 14
Hoang, M. Q., Chung, D. T., & Huynh, Q. T. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s383234 · Cited by 9
“Some studies have shown that disorders of adipose tissue secretion, especially free fatty acids and cytokines, would increase the degree of obesity and decrease the insulin sensitivity of the target tissue (insulin resistance).(3) Insulin resistance causes a compensatory response that increases blood insulin, and long…”
BackgroundAssociation of the PPARγ2 Pro12Ala polymorphism with increased risk of cardiovascular diseases
Li, Y., Zhu, J., & Ding, J. (2015) · Genetics and Molecular Research · doi:10.4238/2015.december.28.15 · Cited by 12
“Evidence has suggested that the activation of PPARγ by thiazolidinedione antidiabetic drugs can result in a higher uptake of fatty acids by adipocytes with the subsequent lowering of circulating free fatty acids, which can mediate many adverse metabolic effects, most notably insulin resistance (Ruiz-Narváez et al., 20…”
BackgroundXylitol: One Name, Numerous Benefits
Chukwuma, C. I., & Islam, M. S. (2016) · Reference series in phytochemistry · doi:10.1007/978-3-319-26478-3_33-1 · Cited by 13
Li, S., Zhu, W., Zhang, S., & Chen, J. D. Z. (2017) · Obesity · doi:10.1002/oby.21852 · Cited by 9
“Chronically elevated plasma FFA in subjects with obesity is thought to arise from the increased secretion from the enlarged and stressed adipose tissue (29,34).”
BackgroundKhemka, V. K., & Banerjee, A. (2017) · Integrative Obesity and Diabetes · doi:10.15761/iod.1000179 · Cited by 11
Niswender, K. D., Fazio, S., Gower, B. A., & Silver, H. J. (2018) · Metabolism · doi:10.1016/j.metabol.2018.01.020 · Cited by 11
Xylitol: One Name, Numerous Benefits
Chukwuma, C. I., & Islam, M. S. (2018) · Reference series in phytochemistry · doi:10.1007/978-3-319-27027-2_33 · Cited by 9
Richard, A. J., Hang, H., Allerton, T. D., Zhao, P., Mendoza, T. M., Ghosh, S., Elks, C. M., & Stephens, J. M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.812802 · Cited by 10
Regan-Smith, S., Fritzen, R., Hierons, S. J., Ajjan, R., Blindauer, C. A., & Stewart, A. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810302 · Cited by 9
Lafontan, M. (2012) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2012.07.008 · Cited by 11
Simino, L. A. D. P., Panzarin, C., Torsoni, M. A., Ignácio-Souza, L. M., Milanski, M., & Torsoni, A. S. (2020) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s204017442000094x · Cited by 10
Palmitic acid-induced defects in cell cycle progression and cytokinesis in Neuro-2a cells
Urso, C. J., & Zhou, H. (2022) · Cell Cycle · doi:10.1080/15384101.2022.2040769 · Cited by 8
“The concentration of PA in the plasma [23,24] and cerebrospinal fluid [25] as well as the uptake and accumulation of PA [26] are increased in obese humans.”
BackgroundMolecular Mechanisms Involved in Insulin Resistance: Recent Updates and Future Challenges
Singh, A., Ghai, N., & Bedi, P. M. S. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.104806 · Cited by 9
Swarnamali, H., Ranasinghe, P. D., & Jayawardena, R. (2024) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2024.103070 · Cited by 9
Li, S., Zou, J., Ran, J., Wang, L., Nie, G., Liu, Y., Tian, C., Yang, X., Liu, Y., Wan, J., et al. (2024) · International Journal of General Medicine · doi:10.2147/ijgm.s494759 · Cited by 9
He, X., Guan, H., Liang, W., Huang, Z., Xu, L., Zhang, P., Xu, F. L., & Li, Y. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0024-2 · Cited by 8
“An increasing large body of evidence points toward dysfunctional adipose tissue as a major determinant of metabolic impairments in individuals with abdominal obesity [18, 19].”
BackgroundThe androgen receptor in bone marrow progenitor cells negatively regulates fat mass
Russell, P. K., Mangiafico, S. P., Fam, B. C., Clarke, M. V., Marin, E. S., Andrikopoulos, S., Wiren, K. M., Zajac, J. D., & Davey, R. A. (2018) · Journal of Endocrinology · doi:10.1530/joe-17-0656 · Cited by 9
“Consistent with notion, in the retroperitoneal VAT of PC-AR Gene Replacements, we observed increases in the expression of genes involved in fatty acid metabolism (Pparα and Scd1), lipogenesis (Acaca) and lipolysis (Pnpla2) as well as increased serum levels of NEFA, which in the fasting state, arise almost entirely fro…”
BackgroundJanssen, L. G. M., Jauhiainen, M., Olkkonen, V. M., Haridas, P. A. N., Nahon, K. J., Rensen, P. C. N., & Boon, M. R. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081214 · Cited by 9
“Interestingly, an increased fat mass is associated with an impaired FFA release from subcutaneous WAT [48].”
BackgroundMüller-Eigner, A., Sanz‐Moreno, A., de Diego, I., Venkatasubramani, A. V., Langhammer, M., Gerlini, R., Rathkolb, B., Aguilar‐Pimentel, J. A., Klein‐Rodewald, T., Calzada‐Wack, J., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03339-3 · Cited by 10
The Gut Microbiota and Effects on Metabolism
Hussey, S. E., & Bergman, M. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386456-7.02009-8 · Cited by 9
Deep subcutaneous adipose tissue lipid unsaturation associates with intramyocellular lipid content
Lundbom, J., Bierwagen, A., Bódis, K. B., Szendrödi, J., Kaprio, J. A., Rissanen, A., Lundbom, N. M. I., Roden, M., & Pietiläinen, K. H. (2016) · Metabolism · doi:10.1016/j.metabol.2016.05.010 · Cited by 9
“During the postprandial period, lipolysis is suppressed and fat storage upregulated, while even a single bout of exercise increases lipolytic release ofNEFA from adipose tissue [9].”
BackgroundHung, C., Bronec, C., Napoli, E., Graham, J. L., Stanhope, K. L., Marsilio, I., Giron, M. C., Havel, P. J., & Giulivi, C. (2018) · Biochemical Journal · doi:10.1042/bcj20170899 · Cited by 9
Insulin resistance and testosterone level in Indonesian young adult males
Kurniawan, L. B., Adnan, E., Windarwati, & Mulyono, B. E. (2020) · Romanian Journal of Internal Medicine · doi:10.2478/rjim-2020-0004 · Cited by 10
Intrahepatic triglyceride content: influence of metabolic and genetics drivers
Dearlove, D., & Hodson, L. (2022) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000838 · Cited by 10
“The authors suggested that the apparent protective effect of adiposity may reflect increased inhibition of lipolysis secondary to elevated serum insulin levels [14 & ]; however, others have reported that NEFA release per kilogram of adipose tissue mass is decreased with obesity [15].”
BackgroundMatsumoto, K., Shimada, H., Morishima, H., Akahori, R., & Kida, N. (2019) · Starch - Stärke · doi:10.1002/star.201900042 · Cited by 8
Vizioli, C., Jaime-Lara, R. B., Franks, A. T., Ortiz, R. V., & Joseph, P. V. (2020) · Biological Research For Nursing · doi:10.1177/1099800420942900 · Cited by 10
“Although the mechanisms by which SAT and NEFAs influence IR and T2DM remain unclear, previous studies have suggested that low-grade inflammation (Longo et al., 2019) and NEFA spillover (a process leading to aggregation of NEFAs in plasma instead of AT) may play a role (Karpe et al., 2011).”
Backgroundvan Zyl, C. L., Bokkers, E. A. M., Kemp, B., Agenäs, S., & van Knegsel, A. T. M. (2025) · Journal of Dairy Science · doi:10.3168/jds.2025-26619 · Cited by 8
Al-Horani, R., Alsays, K. M., & Alrob, O. A. (2023) · European Journal of Applied Physiology · doi:10.1007/s00421-023-05370-6 · Cited by 7
“…inhibition of insulin receptor substrate-1, reduced expression and translocation of glucose transporter 4 in adipocytes and skeletal muscles, and elevated plasma non-esterified fatty acids and intra-myocellular lipid content (Kahn and Flier 2000; Schenk and Horowitz 2007; Karpe et al. 2011).”
Hong, Y., Song, G., Feng, X., Niu, J., Wang, L., Yang, C., Luo, X., Zhou, S., & Ma, W. (2024) · Foods · doi:10.3390/foods13071124 · Cited by 7
Ábel, T., Benczúr, B., & Csobod, É. C. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1458025 · Cited by 8
“However, the results so far are conflicting as to whether the two sexes are the same or whether women have higher levels of FFAs in obesity (56, 57).”
BackgroundResultMetabolic phenotypes and fatty acid profiles associated with histopathology of primary aldosteronism
Yang, Y., Liu, Y., Williams, T. A., Gao, M., Yan, Y., Bao, M., Tao, J., Ma, G., Wang, M., Xia, Z., et al. (2025) · Hypertension Research · doi:10.1038/s41440-025-02143-w · Cited by 8
Benefits of the soluble and insoluble fractions of bitter gourd in mice fed a high-fat diet
Xu, J., Cao, K. J., Feng, Z., & Liu, J. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.01.002 · Cited by 7
Stamborowski, S. F., Lima, F. P. S., Leonardo, P. S., & Lima, M. O. (2021) · International Journal of Photoenergy · doi:10.1155/2021/5519709 · Cited by 10
“In order to understand the nature of skeletal muscle fatigue, we must take into account external factors such as injuries and disuse that somehow influence the fatigue mechanism and the internal factors, which include cell signaling, vascular function, neurophysiology, bioenergetics, and molecular mechanics [34, 35].”
BackgroundAdipocytes in obesity: A perfect reservoir for SARS-CoV-2?
Zhu, J., Wilding, J. P. H., & Hu, J. (2023) · Medical Hypotheses · doi:10.1016/j.mehy.2023.111020 · Cited by 7
“In parallel, excess FFAs could systemically boost SARS-CoV-2 transmission by directly assisting membrane fusion between virus and other host cells (than adipocytes) in obesity [17].”
Finucane, F. M., Rafey, M. F., Leahy, M. J., O’Shea, P. M., O'Brien, T., & O'Donnell, M. J. (2023) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2023.200192 · Cited by 7
Casey, B. A., Kohrt, W. M., Schwartz, R. S., & Pelt, R. E. V. (2014) · Obesity · doi:10.1002/oby.20703 · Cited by 7
“Insulin resistance at the level of the adipocyte (in vitro lipolysis) was also related to systemic hyperinsulinemia in those postmenopausal women (9), consistent with the associations observed in men at the level of abdominal tissue (artereo-venous balance) (6).”
BackgroundResultInfluentialThe Effect of HIV and Art on the Development of Hypertension and Type 2 Diabetes Mellitus
Maseko, T., & Masuku, S. (2017) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000732 · Cited by 8
Lee, D., Yoo, J.-H., & Lee, B.-C. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/8159261 · Cited by 7
Ardizzone, A., Lanza, M., Casili, G., Campolo, M., Paterniti, I., Cuzzocrea, S., & Esposito, E. (2022) · Nutrients · doi:10.3390/nu14112251 · Cited by 8
“A physiological increase in non-esterified fatty acids (NEFA) and triglycerides (TG) plasma levels is usually observed after an intake of a high-fat meal [43,44].”
BackgroundWang, Y. E., Kirschke, C. P., Woodhouse, L. R., Bonnel, E. L., Stephensen, C. B., Bennett, B. J., Newman, J. W. I., Keim, N. L., & Huang, L. (2022) · BMC Nutrition · doi:10.1186/s40795-022-00592-x · Cited by 10
Fadini, G. P., Tura, A., Pacini, G., Avogaro, A., & de Kreutzenberg, S. V. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.03.002 · Cited by 7
Naidoo, D. P., & Prakaschandra, R. (2018) · Journal of Cardiovascular Echography · doi:10.4103/jcecho.jcecho_71_17 · Cited by 8
“The relationship between EAT and MetS may be attributed to the inflammatory milieu that underpins the pathophysiology of both conditions,[11,33,34] as well as that they are both reflective of central obesity.”
BackgroundTrim, W. V., Thompson, D., & Turner, J. E. (2017) · Springer eBooks · doi:10.1007/978-1-4614-6439-6_101903-1 · Cited by 7
Metadata
- Authors
- Karpe, F., Dickmann, J. R., & Frayn, K. N.
- Affiliations
- John Radcliffe Hospital (GB)
- University of Oxford (GB)
- Corresponding author
- Karpe, Fredrik
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2011-09-16
- Volume
- 60
- Issue
- 10
- Pages
- 2441-2449
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3178283
- OpenAlex
- W2152688545
- Cited by
- 896
- References
- 91
- Citations by year
- 2026: 29 · 2025: 33 · 2024: 41 · 2023: 45 · 2022: 73 · 2021: 72 · 2020: 76 · 2019: 74 · 2018: 68 · 2017: 85 · 2016: 76 · 2015: 78 · 2014: 57 · 2013: 53 · 2012: 31
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- University of Oxford
- Institut National de la Santé et de la Recherche Médicale
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- free fatty acids, obesity, insulin resistance, adipose tissue lipolysis, fatty acid mobilization, plasma albumin binding, triacylglycerol mobilization, insulin signaling
- MeSH terms
- Adipose Tissue, Diabetes Mellitus, Fatty Acids, Nonesterified, Humans, Insulin Resistance, Obesity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.